Top Abstract Purchase Related
Home
>
Node
>
Subnode

Bioavailability of peroral antibiotic preparations

Zak, A.F.

Antibiotiki 22(3): 265-279

1977

ISSN/ISBN: 0003-5637
PMID: 322606
Document Number: 110435
A review is given of studies of the bioavailability of commercial peroral drugs in respect to their therapeutic effectiveness. Factors affecting the absorption of drugs include their chemical properties, the number of particles and their surfaces, the number and form of crystals, the charge of particle surfaces and other physico-chemical characteristics. Results of tests with human volunteers and laboratory animals administered aminosalicylic acid, tetracycline, ampicillin, chloramphenicol, penicillin, erythromycin, phenoxymethylpenicillin, oxytetracycline and other antibiotics in various forms and compounds are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Rasmussen, I.C.; Odenholt, I.; Raab, Y. 2000: Antibiotic prophylaxis in gastrointestinal surgery. Peroral preparations are often better and cheaper than intravenous prophylaxis Lakartidningen 97(26-27): 3156-3158
Ritschel, W.A. 1973: Bioavailability of peroral dosage forms Bollettino Chimico Farmaceutico 112(3): 137-162
Batuashvili, T.A.; Shchedrin, V.I.; Zak, A.F. 1979: Bioavailability of peroral drug forms of oxacillin Antibiotiki 24(8): 611-615
Babálová, M.; Blahová, J.; Hupková, M.; Krcméry, V. 1994: Peroral preparations of cephalosporin antibiotics Casopis Lekaru Ceskych 133(1): 22-24
Békefi, E.; Bozzay, J.; Dávid, A.; Rusznák, I. 1982: Pharmacokinetics of active ingredients liberated according to apparently zero-order kinetics from peroral preparations Acta Pharmaceutica Hungarica 52(5): 200-216
Larsson, O.; Kindmark, H.; Bränström, R.; Berggren, P.O. 1997: Mechanisms of action of peroral antidiabetics. Sulfonylurea preparations block the ATP-dependent potassium channels Lakartidningen 94(48): 4473-4477
Shapovalova, S.P.; Malkova, I.V. 1977: Effect of the peroral use of the antitumor antibiotic, carminomycin, on the immunological reactivity of the body of animals Antibiotiki 22(2): 168-172
Rasmussen, I.C.; Odenholt, I.; Raab, Y. 2000: Peroral antibiotic prophylaxis in upper gastrointestinal surgery. a study of biological availability Lakartidningen 97(26-27): 3174-3176
Firoz, M.; Graber, M. 2001: Bioavailability of US commercial magnesium preparations Magnesium Research 14(4): 257-262
Szyszka, A.; Kaźmierczak, E.; Dziegielewska, G.; Lowicki, Z.; Mrozikewicz, A. 1994: Assessment of bioavailability of magnesium preparations Wiadomosci Lekarskie 47(13-14): 481-483
Farfel, Z.; Levi, A.; Millman, P.; Tamari, I.; Halkin, H. 1977: The bioavailability of Israeli quinidine preparations Harefuah 93(7-8): 207-208
Bokarev, I.N.; Andreeva, V.K.; Astashenko, N.A.; Gol'tiakova, T.V.; Ershov, V.I. 1975: Comparative evaluation of the effectiveness of peroral treatment of patients with chronic posthemorrhagic anemia with iron-containing preparations Klinicheskaia Meditsina 53(11): 110-113
Bron, J.; Vree, T.B.; Damsma, J.E.; Hekster, Y.A.; van der Kleijn, E. 1979: Dissolution, bioavailability and pharmacokinetics of three nitrofuratoin preparations in man Arzneimittel-Forschung 29(10): 1614-1620
Gupta, K.C.; Paul, T.; Mehta, J.M.; Desai, N.K.; Sanghvi, B.; Sheth, U.K. 1976: Study of bioavailability of oral iron preparations Journal of Postgraduate Medicine 22(2): 94-99
Warneke, G.; Setnikar, I. 1993: Bioavailability and pharmacokinetics of fluoride from two glutamine monofluorophosphate preparations Arzneimittel-Forschung 43(5): 584-590
Gastauer, R.; Eltze, M.; Pabst, J. 1979: Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence Arzneimittel-Forschung 29(5): 754-757
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379
Molinaro, M.; Villani, P.; Buggia, I.; Iacona, I.; Zoia, C.; Regazzi, M.B.; Rondanelli, R. 1992: The bioavailability of nicorandil after oral administration of a single dose of 10 or 20 mg preparations Bollettino Chimico Farmaceutico 131(10): 375-379
Terhaag, B.; Donath, F.; Le Petit, G.; Feller, K. 1986: The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison International Journal of Clinical Pharmacology Therapy and Toxicology 24(6): 298-302
Simoni, P.; Sabatini, L.; Baraldini, M.; Mirasoli, M.; Roda, A.; Roda, E. 2002: Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration International Journal of Clinical Pharmacology Research 22(2): 37-45